Cargando…
Sex Disparities in MGMT Promoter Methylation and Survival in Glioblastoma: Further Evidence from Clinical Cohorts
Introduction: Recent studies suggest an overrepresentation of MGMT promoter methylated tumors in females with IDHwt glioblastoma (GBM) compared to males, with a subsequent better response to alkylating treatment. Methods: To reveal sex-bound associations that may have gone unnoticed in the original...
Autores principales: | Smits, Anja, Lysiak, Malgorzata, Magnusson, Andreas, Rosell, Johan, Söderkvist, Peter, Malmström, Annika |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913151/ https://www.ncbi.nlm.nih.gov/pubmed/33546098 http://dx.doi.org/10.3390/jcm10040556 |
Ejemplares similares
-
Do we really know who has an MGMT methylated glioma? Results of an international survey regarding use of MGMT analyses for glioma
por: Malmström, Annika, et al.
Publicado: (2020) -
Methylation associated with long- or short-term survival in glioblastoma patients from the Nordic phase 3 trial
por: Łysiak, Małgorzata, et al.
Publicado: (2022) -
Deletions on Chromosome Y and Downregulation of the SRY Gene in Tumor Tissue Are Associated with Worse Survival of Glioblastoma Patients
por: Łysiak, Małgorzata, et al.
Publicado: (2021) -
Association between MGMT Enhancer Methylation and MGMT Promoter Methylation, MGMT Protein Expression, and Overall Survival in Glioblastoma
por: Zappe, Katja, et al.
Publicado: (2023) -
PROX1 is a novel pathway-specific prognostic biomarker for high-grade astrocytomas; results from independent glioblastoma cohorts stratified by age and IDH mutation status
por: Roodakker, Kenney R., et al.
Publicado: (2016)